Blood Glucose Clinical Trial
Official title:
Study of GLUCUBE Performance, a Non-invasive System for Monitoring Blood Glucose Levels Based on Near Infrared Spectroscopy (NIRS) Technology.
NCT number | NCT04935957 |
Other study ID # | DIA-2021-01 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | March 11, 2024 |
Est. completion date | May 2024 |
Verified date | March 2024 |
Source | iGluco |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study is a prospective, single center, non-interventional, open label clinical investigation. The primary objective of the study is to evaluate the performance of GLUCUBE system compared to the standard glucometer in the determination of blood glucose level in adult patients.
Status | Recruiting |
Enrollment | 105 |
Est. completion date | May 2024 |
Est. primary completion date | April 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: 1. Be = 18 years old. 2. Have a smartphone with an internet connection that allows the installation of GLUCUBE APP 3. Have signed the informed consent. Exclusion Criteria: 1. Subject is currently participating in another clinical investigation or has participated in another clinical investigation in the past 30 days prior to the start of the present study. 2. Pregnant or nursing subjects and those who plan pregnancy during the clinical investigation follow-up period. 3. Presence of other anatomic or comorbid conditions, or other medical, social, or psychological conditions that, in the investigator's opinion, could limit the subject's ability to participate in the clinical investigation or to comply with follow-up requirements, or impact the scientific soundness of the clinical investigation results. 4. Patients with any acute active and/or infectious disease. 5. Patients who have a condition that affects blood circulation in the fingers of the hand, such as Raynaud's phenomenon. 6. Any medical condition that, by the investigator judgment, will increase the risk from hyper and hypoglycemic event: seizures, heart disease, hypoglycemia unawareness, etc. 7. Patients who, in the opinion of the investigator, do not have sufficient manual dexterity to perform the tests themselves. 8. Patients with an inability to maintain stability of the hand during measurement or with progressive disease of the nervous system that affects movement (Parkinson's disease, moderate-severe essential tremor, and other diseases with involuntary movements). 9. Patients suffering from calluses, malformations, or open wounds with bandages. 10. Patients with nail polish or any type of false nail. 11. Subjects who do not understand or cannot follow the Procedures Involved in the Use of the Device Under Investigation. |
Country | Name | City | State |
---|---|---|---|
Spain | Centro de Salud La Algaba | La Algaba | Sevilla |
Lead Sponsor | Collaborator |
---|---|
iGluco |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | User satisfaction | Patient reported satisfaction related to the investigational device: in a 1 to 10 scale: 1 - Disagree, 10 - Agree.
And, if given the choice, will you use GLUCUBE device again? Yes or No |
8 days after the participant enters the study | |
Primary | Performance Evaluation | GLUCUBE system performance in the monitoring and measurement of the blood glucose compared to the standard glucometer (blood capillary glucometer - Bayer Contour®Next).
Each pair of measurements includes one measurement with the standard glucometer (Bayer Contour®Next) and one measurement with GLUCUBE device. |
4 times/day for 1 week | |
Primary | Safety Evaluation | All (Serious) Adverse Events and GLUCUBE device related adverse events: local and systemic effects of GLUCUBE device, and the standard glucometer, including, but not limited to redness, burns, pain, or other complications such as bleeding or local infection will be collected. | All AE will be collected during participation in the study since V1 at V2 (8 days) | |
Secondary | Performance Evaluation | GLUCUBE system performance in the monitoring and measurement of the blood glucose compared to the standardized POC device for the determination of glucose (Accu-Chek® Inform II system).
Each pair of measurements includes one measurement with standardized POC device for the determination of glucose (Accu-Chek® Inform II system) and one measurement with GLUCUBE device. |
through study completion, an average of 8 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04578067 -
Empowering Immigrant Women for Active and Healthy Lifestyle
|
N/A | |
Completed |
NCT04256746 -
Dose Response Study of a Natural Extract for Reducing Post Prandial Blood Glucose
|
N/A | |
Completed |
NCT03254082 -
Glycemic Response of Sorghum
|
N/A | |
Completed |
NCT02536066 -
Daily Physical Activity After Meals -Long Term Effects on Blood Glucose
|
N/A | |
Completed |
NCT00444171 -
Glucose Control by eMPC Algorithm in Peri- and Postoperative Period in Cardiac Surgery Patients
|
N/A | |
Completed |
NCT00302302 -
The Effects of L-arabinose on Intestinal Sucrase Activity in Man
|
Phase 1 | |
Completed |
NCT04378374 -
The Effect of Pulse Flours on Blood Glucose, Satiety and Food Intake
|
N/A | |
Completed |
NCT04451655 -
Glycemic Stability During the Intraoperative Period Among Patients With DM Undergoing CABG Surgery
|
N/A | |
Recruiting |
NCT04989712 -
MOReS Freestyle Libre Validation Study
|
N/A | |
Completed |
NCT05352724 -
Clinical Trial to Evaluate the Efficacy of a Sport Drink After High-intensity Aerobic Exercise
|
N/A | |
Completed |
NCT04260425 -
A Pilot Study Evaluating Oat Polyphenols on Post-prandial Glucose Response
|
N/A | |
Completed |
NCT04258501 -
Exploratory Study of Efficacy on Selected Natural Extracts Reducing Post Prandial Blood Glucose Response
|
N/A | |
Completed |
NCT02968498 -
Blood Glucose Response After Oral Intake of Lactulose in Healthy Volunteers
|
N/A | |
Completed |
NCT02484313 -
The Effect of Snacks on Glycaemic Regulation in Children
|
N/A | |
Withdrawn |
NCT01246492 -
The Effect of Artificial Sweeteners on Blood Glucose Response
|
N/A | |
Completed |
NCT01241253 -
Glycemic Response of Bean-and-rice Meals in Type 2 Diabetes Mellitus
|
Phase 2 | |
Completed |
NCT03914430 -
Breakfast Cereals Consumed in Dairy and Non-dairy Medium: the Effects on Blood Glucose, Satiety and Food Intake
|
N/A | |
Recruiting |
NCT05255783 -
The Performance of Dexcom G6 Glucose Monitoring in Critically Ill Patients
|
N/A | |
Completed |
NCT05573607 -
Effects of a Dietary Supplement on Markers of Glucose Control and Quality of Life
|
N/A | |
Recruiting |
NCT05585801 -
Continuous Glucose Monitoring in Intensive Care Unit
|
N/A |